Juan P. Torres, Medical Doctor, PhD

Universidad de Chile
Santiago, Region Metropolitana, Chile

Disclosure(s): Pfizer: Honoraria; Sanofi: Honoraria

Presentation(s):

• 169 - Universal Immunization Strategy Against Respiratory Syncytial Virus (RSV) Prevention in Chile with Nirsevimab during the 2024 Winter Season: First Southern Hemisphere Nationwide Effectiveness Data

  Thursday, October 17, 2024
  2:45 PM – 2:57 PM US PT